Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bueno, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bueno, R.
(Chest. 1999;116:444S-445S.)
© 1999 American College of Chest Physicians

Mesothelioma Clinical Presentation*

Raphael Bueno, MD, FCCP

* From the Division of Thoracic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.

Correspondence to: Raphael Bueno, MD, FCCP, Division of Thoracic Surgery, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115; e-mail: rbueno{at}bics.bwh.harvard.edu

Objectives: Clinical teaching of treatment for mesothelioma

Design: Case presentation

Setting: Postgraduate course

Patient: A 52-year-old man with chest pain

Interventions: Multimodality therapy consisted of surgery, intrapleural chemotherapy, chemotherapy, and radiation therapy.

Results: Patient is alive and well 2 years after surgery.

Conclusions: Aggressive trimodality therapy for mesothelioma is presented as a successful treatment option.

Key Words: Mesothelioma • case report • multimodality therapy




This article has been cited by other articles:


Home page
 Cancer Res.Home page
K. Uematsu, S. Kanazawa, L. You, B. He, Z. Xu, K. Li, B. M. Peterlin, F. McCormick, and D. M. Jablons
Wnt Pathway Activation in Mesothelioma: Evidence of Dishevelled Overexpression and Transcriptional Activity of {beta}-Catenin
Cancer Res., August 1, 2003; 63(15): 4547 - 4551.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-T. Yang, L. You, K. Uematsu, C.-C. Yeh, F. McCormick, and D. M. Jablons
p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53
Cancer Res., August 1, 2001; 61(16): 5959 - 5963.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.